You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Other hematological and non-hematological malignancies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)

Not yet recruiting
  • Non-hodgkin's Lymphoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 27, 2023

Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

Not yet recruiting
  • Relapsed/Refractory Chronic Lymphocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Jul 13, 2023

Oral Complications in Hematological Malignancies

Not yet recruiting
  • Hematologic Malignancy
    • Assiut, Egypt
      Assiut university
    Mar 6, 2023

    CAR-T Treatment for Hematological Malignancies

    Recruiting
    • Hematological Malignancies
    • Chimeric Antigen Receptor T-cell Therapy
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Sep 11, 2023

      COVID-19 Infection in Hematological Malignancies Patients Trial in Italy

      Recruiting
      • COVID-19 Infection in Hematological Malignancies Patients
        • Brescia, Italy
        • +5 more
        Oct 25, 2022

        Hematologic Malignancy Trial in Tianjin (BR108 injection)

        Recruiting
        • Hematologic Malignancy
        • BR108 injection
        • Tianjin, Tianjin, China
          Tianjin Medical University Cancer Institute and Hospital
        Aug 25, 2023

        "Don't Eat me" Signal in Hematological Malignancies: CD24 as New

        Recruiting
        • Mantle-cell Lymphoma
        • B Cell Chronic Lymphocytic Leukemia
          • Monza, MB, Italy
            Andrea Aroldi
          May 24, 2023

          Hematological Malignancies - SANGUINE

          Recruiting
          • Hematologic Malignancy
          • Blood sampling for HemaChip screening/diagnostic testing
          • Bone marrow sampling
          • Olomouc, Czechia
          • +3 more
          Feb 9, 2023

          Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

          Not yet recruiting
          • Acute Lymphoblastic Leukemia, in Relapse
          • +4 more
          • Utrecht, Netherlands
            Princess Máxima Center for Pediatric Oncology
          Feb 22, 2023

          Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

          Not yet recruiting
          • Hematological Malignancies
          • Allogeneic T cell progenitors, cultured ex-vivo
          • (no location specified)
          Mar 2, 2023

          Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

          Not yet recruiting
          • Acute Lymphoblastic Leukemia
          • +4 more
          • Utrecht, Netherlands
            Princess Máxima Center for Pediatric Oncology
          Feb 20, 2023

          Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

          Not yet recruiting
          • Acute Lymphoblastic Leukemia, in Relapse
          • +4 more
          • Utrecht, Netherlands
            Princess Máxima Center for Pediatric Oncology
          Feb 16, 2023

          Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

          Not yet recruiting
          • Acute Lymphoblastic Leukemia, in Relapse
          • +4 more
          • Utrecht, Netherlands
            Princess Máxima Center for Pediatric Oncology
          Dec 13, 2022

          Toxoplasmosis Trial in Sohag (toxoplasma igG)

          Not yet recruiting
          • Toxoplasmosis
          • toxoplasma igG
          • Sohag, Egypt
            Sohag university Hospital
          Jul 19, 2023

          Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Tianjin (NTQ2494 tablet)

          Recruiting
          • Relapsed/Refractory Acute Myeloid Leukemia (AML)
          • NTQ2494 tablet
          • Tianjin, Tianjin, China
            Hematology Hospital of the Chinese Academy of Medical Sciences
          Sep 17, 2023

          Hematological Malignancies Trial in Limoges ("Blend of ginger and lemon essential oils", "Neutral oil")

          Not yet recruiting
          • Hematological Malignancies
          • "Blend of ginger and lemon essential oils", "Neutral oil"
          • Limoges, France
            University Hospital, Limoges
          Nov 20, 2023

          Lymphoma, Leukemia, Myeloma Trial in Tampa (Resistance Training, Aerobic Exercise)

          Recruiting
          • Lymphoma
          • +2 more
          • Resistance Training
          • Aerobic Exercise
          • Tampa, Florida
            Moffitt Cancer Center
          Feb 28, 2023

          Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

          Recruiting
          • Hematopoietic Malignancy
          • +2 more
          • Umbilical Cord Blood Transplantation
          • Suzhou, Jiangsu, China
            The First Affiliated Hospital of Soochow university
          Nov 6, 2023

          Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)

          Not yet recruiting
          • Hematological Malignancy
          • Solid Tumor
          • (no location specified)
          Apr 24, 2023

          Hematological Malignancies Trial in United States (KPG-818)

          Recruiting
          • Hematological Malignancies
          • Sacramento, California
          • +9 more
          Jul 4, 2022

          Mature B-cell Tumors Trial (Nemtabrutinib)

          Not yet recruiting
          • Mature B-cell Neoplasms
          • (no location specified)
          Jan 13, 2023

          Hematological Malignancies, Thrombocytopenia Trial in Atlanta, Decatur (EACA, Platelet transfusion)

          Terminated
          Has Results
          • Hematological Malignancies
          • Thrombocytopenia
          • EACA
          • Platelet transfusion
          • Atlanta, Georgia
          • +1 more
          Jun 26, 2022

          Hematological Malignancies Trial (Anti-CD7 CAR-T)

          Not yet recruiting
          • Hematological Malignancies
          • Anti-CD7 CAR-T
          • (no location specified)
          Jul 8, 2022

          Hematological Malignancy, COVID-19 Trial in Beijing (Anti-COVID-19 Antibody SA55 for Injection)

          Recruiting
          • Hematological Malignancy
          • COVID-19
          • Anti-COVID-19 Antibody SA55 for Injection
          • Beijing, Beijing, China
            Beijing Boren Hospital
          Jan 9, 2023

          Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)

          Recruiting
          • Solid Tumor
          • Hematological Malignancy
          • East Melbourne, Victoria, Australia
          • +4 more
          Jan 11, 2023